一名服用合成代谢雄激素类固醇的年轻健美运动员发生急性心肌梗死：病例报告及文献综述

Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: A case report and critical review of the literature.

作者信息

Christou Georgios A, Christou Konstantinos A, Nikas Dimitrios N, Goudevenos John A

机构信息

Laboratory of Physiology, Medical School, University of Ioannina, Greece

First Department of Cardiology, University Hospital of Ioannina, Greece.

出版信息

Eur J Prev Cardiol. 2016 Nov;23(16):1785-1796. doi: 10.1177/2047487316651341. Epub 2016 May 16.

DOI:10.1177/2047487316651341

PMID:27184497

Abstract

We describe a case report of a 30-year-old bodybuilder suffering acute myocardial infarction (AMI). He had been taking stanozolol and testosterone for two months. The coronary angiogram showed high thrombotic burden in the left anterior descending artery without underlying atherosclerosis. Few case reports of AMI in athletes taking anabolic androgenic steroids (AASs) have been reported so far. AAS-related AMI is possibly underreported in the medical literature due to the desire of the affected individuals to hide AAS use. Physicians should always consider the possibility of AAS abuse in the context of a young athlete suffering AMI. AASs can predispose to AMI through the acceleration of coronary atherosclerosis. Additionally, thrombosis without underlying atherosclerosis or vasospasm is highly possible to cause AMI in AAS users. Complications after AMI may be more frequent in AAS users.

摘要

我们描述了一例30岁男性健美运动员患急性心肌梗死（AMI）的病例报告。他服用司坦唑醇和睾酮已有两个月。冠状动脉造影显示左前降支血栓负荷高，无潜在动脉粥样硬化。迄今为止，很少有关于服用合成代谢雄激素类固醇（AASs）的运动员发生AMI的病例报告。由于受影响个体希望隐瞒AAS的使用情况，AAS相关的AMI在医学文献中可能报告不足。医生在年轻运动员发生AMI的情况下，应始终考虑AAS滥用的可能性。AAS可通过加速冠状动脉粥样硬化而诱发AMI。此外，在AAS使用者中，无潜在动脉粥样硬化或血管痉挛的血栓形成很可能导致AMI。AAS使用者发生AMI后的并发症可能更常见。